Does RISANKIZUMAB-RZAA Cause Multiple organ dysfunction syndrome? 23 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Multiple organ dysfunction syndrome have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
23
Reports of Multiple organ dysfunction syndrome with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
15
Deaths
12
Hospitalizations
How Dangerous Is Multiple organ dysfunction syndrome From RISANKIZUMAB-RZAA?
Of the 23 reports, 15 (65.2%) resulted in death, 12 (52.2%) required hospitalization, and 2 (8.7%) were considered life-threatening.
Is Multiple organ dysfunction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Multiple organ dysfunction syndrome?
TACROLIMUS (1,847)
CYCLOPHOSPHAMIDE (1,597)
MYCOPHENOLATE MOFETIL (1,566)
PREDNISONE (1,525)
DEXAMETHASONE (1,355)
METHOTREXATE (1,317)
METHYLPREDNISOLONE (1,278)
RITUXIMAB (1,188)
PREDNISOLONE (1,154)
CYCLOSPORINE (933)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Multiple organ dysfunction syndrome Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA